MeSH tree: D02.455.426.392.368.367.652
Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the University of Birmingham ...
Nov 30, 2025
0
65
In Lusaka, Zambia, where clinical improvisation is often essential, Mayo Clinic anesthesiologist Kashmira Chawla, M.D., led a group of senior residents from Mayo Clinic School of Graduate Medical Education (MCSGME) on a collaborative ...
Nov 25, 2025
0
8
Perhaps the most intriguing implication of recent breakthrough research lies in an unexpected connection: the most rigorous mechanistic dissection of rapid antidepressant action identifies adenosine as the critical mediator, ...
Nov 11, 2025
0
106
Everything in moderation. Including moderation. That's the idea behind the Colorado sober movement, an unofficial yet growing trend away from alcohol, and toward plant-based and psychedelic drugs.
Oct 28, 2025
0
20
Findings from a randomized and blinded clinical trial investigating repeated ketamine infusions for treating depression have revealed no extra benefit from ketamine when added to standard care for people admitted to hospital ...
Oct 22, 2025
0
15
The U.S. Food and Drug Administration (FDA) announced that it will fast-track review of nine experimental drugs.
Oct 21, 2025
0
23
The Food and Drug Administration on Thursday announced the first round of experimental drugs that will receive drastically expedited reviews at the agency, part of an effort to prioritize medicines the Trump administration ...
Oct 17, 2025
0
17
Combining psychotherapy with low-dose ketamine, a hallucinogenic drug long used as an anesthetic, is a relatively new approach to treating severe depression and post-traumatic stress, especially in populations with high trauma ...
Oct 15, 2025
0
12
Low-dose IV infusions of ketamine are safe and effective in treating chronic pain, a new study says.
Oct 10, 2025
0
26
A new study shows longer-term use of generic ketamine for severe depression is safe and effective, but researchers say access to the low-cost option remains limited by funding gaps.
Oct 9, 2025
0
26
